Home / Executive Moves / Sujey Edward, Sheri Neely Named Salient VPs; Bill Parker Comments

Sujey Edward, Sheri Neely Named Salient VPs; Bill Parker Comments

Sujey Edward
Sujey Edward

Sujey Edward and Sheri Neely, respectively a former agile coach for federal agencies and a LIST Innovative Solutions veteran, have joined Salient Federal Solutions to serve as vice presidents.

Edward will serve as VP of the company’s agile center of excellence and Neely will lead the company’s mission critical software development unit, Salient said Wednesday.

In his new role, Edward will lead the company’s agility-as-a-service offerings and focus on best practices to deliver scaled agile offerings to agencies and organizations.

Sheri Neely
Sheri Neely

Neely, VP of operations at LIST prior to Salient’s acquisition of that company, will lead the company’s software engineering and information technology infrastructure teams that work in the federal civilian market.

Bill Parker
Bill Parker

She brings experience from projects with the Office of Personnel Management and the Patent and Trademark Office, according to Salient.

“The appointments of Sujey and Sheri are important milestones that will enable our team to maintain a strong strategic focus on the integration of technology, systems, and solutions, ” said Bill Parker, Salient chief operating officer.

Before joining Salient, Edward served as an agile coach for organizations such as the Nuclear Regulatory Commission, Transportation Security Administration and Blue Cross Blue Shield of Kansas.

Before joining LIST, Neely served as a VP and deputy business unit director at SRA International and worked with agencies such as OPM, the Agriculture Department and the Environmental Protection Agency.

Check Also

F5 to Buy Shape Security for $1B; Francois Locoh-Donou Quoted

F5 Networks (Nasdaq: FFIV) has agreed to acquire Santa Clara, Calif.-based Shape Security for approximately $1B in cash as both companies aim to help government and enterprise customers secure digital experience with integrated offerings.

Paratek Secures $169M Anthrax Antibiotic Development Contract Under HHS Project BioShield

The Department of Health and Human Services has awarded Paratek Pharmaceuticals a potential a five-year, $169M contract to further develop an antibiotic drug as a potential treatment for inhalation anthrax.